TP53 and acute lymphoblastic leukemia: We should also point out that the IO IC50 value calculated in primary cells derived from ALL patients at diagnosis or at the time of relapse also correlated with their p53 status, further strengthening the suggestion that p53 integrity predicts for IO efficacy.